Xiang-Qun Hu, Robert W Peoples
Index: J. Biol. Chem. 283(11) , 6826-31, (2008)
Full Text: HTML
Current receptor theory suggests that there is an equilibrium between the inactive (R) and active (R*) conformations of ligand-gated ion channels and G protein-coupled receptors. The actions of ligands in both receptor types could be appropriately explained by this two-state model. Ligands such as agonists and antagonists affect receptor function by stabilizing one or both conformations. The 5-HT3 receptor is a member of the Cys-loop ligand-gated ion channel superfamily participating in synaptic transmission. Here we show that co-expression of the 5-HT3A and 5-HT3B receptor subunits in the human embryonic kidney (HEK) 293 cells results in a receptor that displays a low level of constitutive (or agonist-independent) activity. Furthermore, we also demonstrate that the properties of ligands can be modified by receptor composition. Whereas the 5-hydroxytryptamine (5-HT) analog 5-methoxyindole is a partial agonist at the 5-HT3A receptor, it becomes a "protean agonist" (functioning as an agonist and an inverse agonist at the same receptor) at the 5-HT3AB receptor (after the Greek god Proteus, who was able to change his shape and appearance at will). In addition, the 5-HT analog 5-hydroxyindole is a positive allosteric modulator for the liganded active (AR*) conformation of the 5-HT3A and 5-HT3AB receptors and a negative allosteric modulator for the spontaneously active (R*) conformation of the 5-HT3AB receptor, suggesting that the spontaneously active (R*) and liganded active (AR*) conformations are differentially modulated by 5-hydroxyindole. Thus, the incorporation of the 5-HT3B subunit leads to spontaneous channel opening and altered ligand properties.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
5-Methoxyindole
CAS:1006-94-6 |
C9H9NO |
Prediction of Setschenow constants of N-heteroaromatics in N...
2016-02-01 [Environ. Sci. Pollut. Res. Int. 23 , 3399-405, (2016)] |
Assessment of the pharmacological properties of 5-methoxyind...
2012-08-01 [J. Pharm. Pharmacol. 64(8) , 1099-106, (2012)] |
Rotationally resolved electronic spectroscopy of 5-methoxyin...
2010-07-14 [J. Chem. Phys. 133(2) , 024303, (2010)] |
Generation of new protein kinase inhibitors utilizing cytoch...
2004-06-03 [J. Med. Chem. 47(12) , 3236-41, (2004)] |
Optimization of the interligand Overhauser effect for fragme...
2010-04-07 [J. Am. Chem. Soc. 132(13) , 4544-5, (2010)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved